Entamoeba histolytica carbonic anhydrase

Seppo Parkkila1

  • 1Faculty of Medicine and Health Technology, Tampere University and Department of Clinical Chemistry, Fimlab Laboratories Ltd, Tampere University Hospital, Tampere, Finland.

The Enzymes
|October 8, 2025
PubMed
Summary

Amoebiasis, a parasitic infection affecting 10% of the global population, requires new treatments. Research into Entamoeba histolytica's β-carbonic anhydrase (EhiCA) shows promise for novel antiamoebic therapies.